POSTER SESSION III
Tuesday, March 23, 2010 — 9:30 AM - 12:00 Noon
Exhibit Hall
Click on the blue numbers in parentheses to display abstracts.
Click the button next to any title to add to Itinerary Planner...
HEMATOPATHOLOGY
Poster#
Title and Authors
Itinerary Planner
193
Nuclear Expression of MATK Is a Novel Marker of Type II Enteropathic T-Cell Lymphoma and NK/T Cell Lymphoma
(1450)
SY Tan, AS Ooi, J Ngeow, L Tan, BT Teh - Singapore General Hospital, Singapore, Singapore; National Cancer Centre, Singapore, Singapore
Activation of p53 by Nutlin-3a, an Mdm2 Antagonist, Induces Downregulation of Akt-mtor Oncogenic Signaling in Alk+ Anaplastic Large Cell Lymphoma Cells
(1313)
E Drakos, GZ Rassidakis, E Schlette, J Li, JL Medeiros - MD Anderson Cancer Center, Houston, TX; Medical School, University of Athens, Athens, Greece
Comparative Genomic Hybridization Array of Angioimmunoblastic T-Cell Lymphomas with and without Large B-Cell Proliferations
(1374)
JH Kurzer, L Ma, DA Arber - Stanford University Medical Center, Stanford, CA
PAX5-Positive T-Cell Anaplastic Large Cell Lymphomas Associated with Extra Copies of the PAX5 Gene Locus
(1323)
AL Feldman, ME Law, DJ Inwards, A Dogan, RF McClure, WR Macon - Mayo Clinic, Rochester, MN
Clinical and Pathological Implications of Foxp3 Expression in Adult T-Cell Leukemia/Lymphoma in US/Caribbean Cases
(1408)
J Ouyang, SRS Gottesman, K Killoran, K Leveaux, A Braverman, X Zhang, V Kaushik, CA Axiotis - SUNY Downstate Medical Center, Brooklyn, NY; Kings County Medical Center, Brooklyn, NY
CD30 Expression Correlates with Increased Levels of the Anti-Apoptotic Protein BAG-3 in T-Cell Lymphomas
(1363)
L Jiang, C Cocklin, D Menke, KA Rizzo - Indiana University, Indianapolis, IN; Mayo Clinic, Jacksonville, FL
BCL11b Gene Is Targeted by Structural and Numerical Chromosomal Aberrations in Mature T-Cell Lymphoma
(1344)
E Haralambieva, E Leich, E Marques-Maggio, E Bachmann, A Zettl, A Rosenwald, HK Mueller-Hermelink, K Pulford - University of Wuerzburg, Wuerzburg, Germany; Viollier AG, Basel, Switzerland; Oxford University, Oxford, United Kingdom
Clinicopathologic Spectrum of Non-Hepatosplenic gamma-delta T-Cell Lymphoma: A Review of 19 Cases
(1442)
JY Song, A Garcia-Herrera, SS Chuang, F Climent, S Pittaluga, M Raffeld, P Gaulard, E Campo, A Martinez, ES Jaffe - National Cancer Institute, Bethesda, MD; Hospital Clinic, University of Barcelona, Barcelona, Spain; Hospital Henri Mondor, Creteil, France; Chi-Mei Medical Center, Taipei Medical University, Taipei, Taiwan
Immunophenotypic Stability of T-Cell Large Granular Lymphocytic Leukemia and Chronic Lymphoproliferative Disorders of NK Cells by Flow Cytometry
(1444)
MD Spears, AM Harrington, SH Kroft, H Olteanu - MCW, Milwaukee, WI
CD 23 Expression in Plasma Cell Myeloma with t(11;14)
(1452)
RN Tawil, Q Ahmed, AN Mohamed, G Bentely - Wayne State University School of Medicine, Detroit, MI; Detroit Medical Center, Detroit, MI
Plasmacytoma Expressing Immunoglobulin A: A Clinicopathologic Analysis of 8 Cases
(1438)
H Shao, L Xi, M Raffeld, S Pittaluga, K Dunleavy, W Wilson, N Spector, D Azambuja, ES Jaffe - National Cancer Institute, National Cancer Institute, Bethesda, MD; Federal University of Rio de Janeiro, Rio de Janeiro, Brazil
Analysis of High-Risk Genomic Aberrations in Light Chain Only Multiple Myeloma
(1418)
C Qi, Y Trieu, W Xu, D Reece, H Chang - University Health Network, University of Toronto, Toronto, Canada
High-Risk Plasma Cell Myeloma Cytogenetic Markers Are More Prevalent in African-Americans
(1448)
L Taddesse-Heath, J Scheerle, JC Kelly, A Meloni-Ehrig - Howard University Hospital, Washington, DC; Quest Diagnostics Nichols Institute, Chantilly, VA
Plasma Cell Myeloma: Can Histologic Grade Predict the Molecular Subsets?
(1354)
OF Ikpatt, JD Shaughnessy, BP Nair, ZN Singh - University of Arkansas for Medical Sciences, Little Rock, AR
Immunophenotypic Stability in Plasma Cell Myeloma by Flow Cytometry
(1443)
MD Spears, H Olteanu, SH Kroft, AM Harrington - Medical College of Wisconsin, Milwaukee, WI
Prognostic Relevance of Immunophenotype and 6q Deletions in Waldenstrom's Macroglobulinemia
(1360)
A Jiang, C Qi, Y Trieu, W Xu, D Reece, C Chen, H Chang - University Health Network, Toronto, Canada
RITA Induces Apoptosis in Multiple Myeloma Cells Independent of p53 Mutation Status
(1283)
A Azuma-Mukai, MN Saha, H Chang - University of Toronto, Toronto, Canada
CKS1B Overexpression and Genomic Analysis in Multiple Myeloma
(1364)
N Jiang, J Jiang, W Xu, Y Trieu, C Qi, D Reece, H Chang - University Health Network, University of Toronto, Toronto, Canada
Bone Marrow Derived Mesenchymal Stem Cells from Myeloma Patients Support the Growth of Myeloma Stem Cells
(1413)
M Perez, Y Feng, J Wen, DS Choi, Y Zu, C-C Chang - The Methodist Hospital and The Methodist Hospital Research Institute, Houston, TX; Tongji Medical College in Huangzhong University of Science and Technology, Wuhan, Hubei, China; Weill Medical College of Cornell University, New York, NY
Sclerosing Inflammatory Pseudotumor of the Orbit: An IgG4-Related Disease
(1371)
VE Klepeis, V Deshpande, AR Sohani, JA Ferry - Massachusetts General Hospital, Boston, MA
Utility of D2-40 Expression and the Microenvironment in Distinguishing Inflammatory Pseudotumors from Follicular Dendritic Cell Tumors of Lymph Node and Spleen: Clinicopathologic Comparison of 6 Cases
(1356)
M Jamali, DJ Bailey - University Health Network, Toronto, ON, Canada
CD123 and CD2AP Immunohistochemical Staining Shows Plasmacytoid Dendritic Cells Are Present in All Reactive Lymph Nodes but Their Numbers and Growth Pattern Vary Based on Pathologic Diagnosis
(1427)
MA Rollins-Raval, SH Swerdlow, T Marafioti, CF Garcia - University of Pittsburgh School of Medicine, Pittsburgh, PA; John Radcliffe Hospital, Oxford, United Kingdom
SPI-B a Novel Immunohistochemical Marker for Human Plasmacytoid Dendritic Cell Neoplasms. Characterization of Its Expression in Major Haematolymphoid Neoplasms
(1397)
S Montes-Moreno, R Ramos, G Roncador, F Acquadro, SM Rodriguez-Pinilla, R Pajares, L Sanchez, MA Piris - CNIO, Madrid, Spain
Immunohistochemical and Molecular Cytogenetic Evaluation of Potential Targets for Tyrosine Kinase Inhibitors in Langerhans Cell Histiocytosis
(1296)
GC Caponetti, RC Streblow, PA Althof, WG Sanger, TC Greiner, DD Weisenburger - University of Nebraska Medical Center, Omaha, NE
Coexistence of Langerhans Cell Histiocytosis and Rosai-Dorfman Disease: Related-Disorders?
(1317)
A Duong, DP O'Malley, TS Barry, S Chen, JA Ferry, RP Hasserjian, MA Thompson, MS Richardson, R Jaffe, JS Sidhu, PM Banks - Medical University of South Carolina, Charleston, SC; Clarient Inc, Aliso Viejo, CA; Massachusetts General Hospital, Boston, MA; Vanderbilt, Nashville, TN; Children's Hospital of Pittsburgh, Pittsburgh, PA; UHS Hospitals, Binghamton, NY; Carolinas Medical Center, Charlotte, NC
Expression of PU.1 in Histiocytic and Dendritic Cell Neoplasms and Histologic Mimics
(1429)
MB Ruzinova, JL Hornick - Brigham and Women's Hospital, Harvard Medical School, Boston, MA
button next to any title to add to Itinerary Planner...
Add
